| Circulating tumor cells in metastatic breast cancer: from genome instability to metastasis E Ivanova, A Ward, AP Wiegmans, DJ Richard Frontiers in Molecular Biosciences 7, 134, 2020 | 19 | 2020 |
| DYRK3 contributes to differentiation and hypoxic control in neuroblastoma E Ivanova, SD Sharma, A Brichkina, P Pfefferle, U Keber, A Pagenstecher, ... Biochemical and Biophysical Research Communications 567, 215-221, 2021 | 7 | 2021 |
| Genome instability and pressure on non-homologous end joining drives chemotherapy resistance via a DNA repair crisis switch in triple negative breast cancer AP Wiegmans, A Ward, E Ivanova, PHG Duijf, MN Adams, IM Najib, ... NAR cancer 3 (2), zcab022, 2021 | 7 | 2021 |
| Identifying therapies to combat epithelial mesenchymal plasticity-associated chemoresistance to conventional breast cancer therapies using an shRNA library screen S Bhatia, T Blick, C Pinto, M Waltham, J Monkman, E Ivanova, PM Pollock, ... Cancers 12 (5), 1123, 2020 | 6 | 2020 |
| Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer AP Wiegmans, E Ivanova, VY Naei, J Monkman, J Fletcher, W Mullally, ... Clinical & Experimental Metastasis, 1-10, 2024 | | 2024 |
| Characterisation of circulating tumor‐associated and immune cells in patients with advanced‐stage non‐small cell lung cancer VY Naei, E Ivanova, W Mullally, CG O'Leary, R Ladwa, K O'Byrne, ... Clinical & Translational Immunology 13 (6), 2024 | | 2024 |
